COMMENTARY: The Thrombolysis In Myocardial Infarction risk index predicted in-hospital mortality in non-ST-segment elevation myocardial infarction
- Left ventricular thrombus formation after acute myocardial infarction. Delewi, Ronak; Zijlstra, Felix; Piek, Jan J. // Heart;Dec2012, Vol. 98 Issue 23, p1742
The article offers information on the risks related to the formation of left ventricular (LV) thrombus after the occurrence of acute myocardial infarction (AFI). It informs that the risk of LV thrombus formation is highest during the first 3 months of following acute myocardial infarction. It...
- Eficacia y seguridad de la trombÃ³lisis intracoronaria con estreptoquinasa en pacientes con infarto agudo al miocardio. Navarro, José Roberto Durán; Acuña, Jorge; Ayache, Mauricio Kuri; Fernández, Carlos Rafael Sierra; Macías, Manuel Ben Adoniram Gaxiola; Valdés, Xenia Serrano // Archivos de Medicina de Urgencia de MÃ©xico;sep-dic2013, Vol. 5 Issue 3, p97
Introduction: Acute myocardial infarction remains one of the major causes of mortality worldwide. Recent advances have greatly reduced mortality; however, new challenges arise in the post-reperfusion era. The use of intracoronary thrombolysis arises again as an effective therapy in patients who...
- Moderate alcohol consumption before and after heart attack associated with lower mortality. // Biomedical Market Newsletter;4/21/2012, Vol. 21, p1
The article focuses on a follow-up study, according to which men who consumed alcohol moderately before and after heart attacks were associated with lower mortality.
- Long-term Outcome of Primary Percutaneous Coronary Intervention vs Prehospital and In-Hospital Thrombolysis for Patients With ST-Elevation Myocardial Infarction. Stenestrand, Ulf; Lindbäck, Johan; Wallentin, Lars // JAMA: Journal of the American Medical Association;10/11/2006, Vol. 296 Issue 14, p1749
The article presents a medical study comparing and evaluating the outcome of different reperfusion strategies, including percutaneous coronary intervention and prehospital and in-hospital thrombolysis, in patients with ST-segment elevation myocardial infarction (STEMI). The observational cohort...
- Effect of Tilarginine Acetate in Patients With Acute Myocardial Infarction and Cardiogenic Shock. // JAMA: Journal of the American Medical Association;4/18/2007, Vol. 297 Issue 15, p1657
The article presents a randomized controlled trial that examined the effects of the nitric oxide synthase inhibitor tilarginine acetate in patients with myocardial infarction and refractory cardiogenic shock. All patients in the study had an open infarct artery. Outcomes measured in the study...
- Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction. French, John K.; Williams, Barbara F. // BMJ: British Medical Journal (International Edition);6/29/96, Vol. 312 Issue 7047, p1637
Determines the proportion of patients presenting with acute myocardial infarction who are eligible for thrombolytic therapy in Auckland, New Zealand. Eligibility for thrombolytic therapy; Mortality rates of myocardial infarction patients; Cautions with thrombolytic therapy. INSET: Key messages..
- Time delays in provision of thrombolytic treatment in six district. Birkhead, J.S. // BMJ: British Medical Journal (International Edition);8/22/92, Vol. 305 Issue 6851, p445
Measures the delay between onset of symptoms and admission to hospital and provision of thrombolysis in patients acute myocardial infarction. Response time by patients; Trends in emergency services; Reduction of symptoms to thrombolysis by more effective use of emergency services.
- Intracoronary Thrombolysis in Evolving Myocardial Infarction. Ganz, William // Annals of Internal Medicine;Oct81, Vol. 95 Issue 4, p500
Editorial. Comments on the intracoronary thrombolysis in evolving myocardial infarction. Morbidity and mortality of myocardial necrosis; Time limit set for considering patients for reperfusion; Clinical studies with intracoronary thrombolysis.
- Outcome of Patients with Acute Myocardial Infarction Who Are Ineligible for Thrombolytic Therapy. Cragg, David R.; Friedman, Harold Z.; Bonema, John D.; Jaiyesimi, Ishmael A.; Ramos, Renato G.; Timmins, Gerald C.; O'Neill, William; Schreiber, Theodore L. // Annals of Internal Medicine;8/1/91, Vol. 115 Issue 3, p173
Focuses on a study which determined the outcome of patients with acute myocardial infarction, who are ineligible for thrombolytic therapy. Information on thrombolytic therapy; Methodology of the study; Results and discussion.